Even if acetylcholinesterase (AChE) inhibitors (donepezil, galantamine, or rivastigmine) stop the breakdown of synaptic acetylcholine (ACh), enhancing the cholinergic and cognitive functions, which deteriorate in normal aging and AD, they have some important limitations [26]. Here, ACHE is linked to Alzheimer disease.